Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Inflammatory Mediators in Late Antigen-Induced Rhinitis
1985589 citationsAnne Kagey‐Sobotka, Marshall Plaut et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Philip S. Norman
Since
Specialization
Citations
This map shows the geographic impact of Philip S. Norman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip S. Norman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip S. Norman more than expected).
Fields of papers citing papers by Philip S. Norman
This network shows the impact of papers produced by Philip S. Norman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip S. Norman. The network helps show where Philip S. Norman may publish in the future.
Co-authorship network of co-authors of Philip S. Norman
This figure shows the co-authorship network connecting the top 25 collaborators of Philip S. Norman.
A scholar is included among the top collaborators of Philip S. Norman based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Philip S. Norman. Philip S. Norman is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Golden, David B.K., Anne Kagey‐Sobotka, Philip S. Norman, Robert G. Hamilton, & Lawrence M. Lichtenstein. (2001). Insect sting allergy with negative venom skin test responses. Journal of Allergy and Clinical Immunology. 107(5). 897–901.107 indexed citations
Wolfe, Jeremy D., Marshall Plaut, Philip S. Norman, & L M Lichtenstein. (1979). The effect of an H2 receptor antagonist on immediate and delayed skin test reactivity in man. Journal of Allergy and Clinical Immunology. 63(3).7 indexed citations
13.
Norman, Philip S., David G. Marsh, & L.M. Lichtenstein. (1979). Long-term immunotherapy with ragweed allergen and allergoid. Journal of Allergy and Clinical Immunology. 63(3).7 indexed citations
14.
Norman, Philip S.. (1976). Presidential address. Journal of Allergy and Clinical Immunology. 57(6). 513–517.1 indexed citations
15.
Norman, Philip S., David G. Marsh, L M Lichtenstein, & Kazuhiro Ishizaka. (1975). Immunologic and clinical responses to ragweed extract and its allergoid. Journal of Allergy and Clinical Immunology. 55(2). 78.3 indexed citations
16.
Rosenthal, Richard R., W. R. Summer, Solbert Permutt, & Philip S. Norman. (1974). Effect of atropine on antigen mediated bronchospasm. Journal of Allergy and Clinical Immunology. 53(2).3 indexed citations
Norman, Philip S., Walter L. Winkenwerder, & Lawrence M. Lichtenstein. (1971). Maintenance immunotherapy in ragweed hay fever. Booster injections at six week intervals.. PubMed. 47(5). 273–82.34 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.